Immune Attunement: Fortifying Anti-Tumor Immunity Via T Cell Co-Stimulation

Immune Attunement: Fortifying Anti-Tumor Immunity Via T Cell Co-Stimulation

Bibliographic Details
Main Author:	Do, Priscilla
Language:	English
Published:	The Ohio State University / OhioLINK 2017
Subjects:	Biomedical Research Immunology CTLA-4 immune therapy cancer checkpoint blockade CC-122
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1492568422442233

Similar Items

Acquired Resistance to Immune Checkpoint Blockade Therapies
by: Xianda Zhao, et al.
Published: (2020-05-01)

Combination immune checkpoint blockade as an effective therapy for mesothelioma
by: Vanessa S. Fear, et al.
Published: (2018-10-01)

Motility Dynamics of T Cells in Tumor-Draining Lymph Nodes: A Rational Indicator of Antitumor Response and Immune Checkpoint Blockade
by: Yasuhiro Kanda, et al.
Published: (2021-09-01)

Tremelimumab: research and clinical development
by: Comin-Anduix B, et al.
Published: (2016-03-01)

Immune Checkpoint Molecules in Reproductive Immunology
by: Eva Miko, et al.
Published: (2019-04-01)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis
by: Elias A. T. Koch, et al.
Published: (2021-07-01)

Combinatorial Approaches to Enhance Anti-Tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
Published: (2019)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
by: Maria Georganaki, et al.
Published: (2018-12-01)

TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
by: Jinah Yeo, et al.
Published: (2021-02-01)

Does the immune system naturally protect against cancer?
by: Alexandre eCorthay, et al.
Published: (2014-05-01)

Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade
by: Jingye Li, et al.
Published: (2021-08-01)

Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model
by: Cameron S. Field, et al.
Published: (2018-01-01)

CTLA-4 correlates with immune and clinical characteristics of glioma
by: Fangkun Liu, et al.
Published: (2020-01-01)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
by: Yangzhi Qi, et al.
Published: (2020-11-01)

Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer
by: Yaru Tian, et al.
Published: (2019-06-01)

Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report
by: D. E. Meyers, et al.
Published: (2018-03-01)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
by: Florent Petitprez, et al.
Published: (2020-05-01)

Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
by: Patrik Andersson, et al.
Published: (2019-09-01)

Cervical Cancer: Emerging Immune Landscape and Treatment
by: Guo L, et al.
Published: (2020-08-01)

Dissecting the Immune Landscape of Acute Myeloid Leukemia
by: Jan Davidson-Moncada, et al.
Published: (2018-11-01)

A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapy
by: Frederick S. Varn, et al.
Published: (2019-01-01)

Classification of Non-Small Cell Lung Cancer’s Tumor Immune Micro-Environment and Strategies to Augment Its Response to Immune Checkpoint Blockade
by: Alexander Chi, et al.
Published: (2021-06-01)

CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade
by: Julie Vackova, et al.
Published: (2021-04-01)

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
by: Rachael M. Zemek, et al.
Published: (2020-02-01)

Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
by: Rachel L. Y. Ho, et al.
Published: (2021-07-01)

The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
by: Bonnie L. Russell, et al.
Published: (2021-06-01)

Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models
by: Yasuhiro Maruoka, et al.
Published: (2020-09-01)

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade
by: Eric Bartee, et al.
Published: (2017-05-01)

Immune Checkpoint Molecules and Cancer Immunotherapy
Published: (2019)

Tumor-targeting anti-EGFR x anti-PD1 bispecific antibody inhibits EGFR-overexpressing tumor growth by combining EGFR blockade and immune activation with direct tumor cell killing
by: Li Li, et al.
Published: (2021-01-01)

Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib
by: Yuting Lu, et al.
Published: (2021-09-01)

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery
by: Molly A. Taylor, et al.
Published: (2019-11-01)

Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes
by: Laura Gámez-Díaz, et al.
Published: (2021-08-01)

Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response
by: Bridget P. Keenan, et al.
Published: (2019-10-01)

Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
by: Wei Xie, et al.
Published: (2019-11-01)

Opportunistic autoimmune disorders potentiated by immune-checkpoint inhibitors anti-CTLA-4 and anti-PD-1
by: Yi-Chi eKong, et al.
Published: (2014-05-01)

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
by: Florian Huemer, et al.
Published: (2021-01-01)

Immune-Mediated Therapies for Liver Cancer
by: Rajagopal N. Aravalli, et al.
Published: (2017-02-01)

Role of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progress
by: Zin W. Myint, et al.
Published: (2017-04-01)

The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer
by: Xiangzheng Liu, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_m4ublec63fl6o8d04k62t1qenl